National Utilization and Expenditure Trends of GLP-1 Receptor Agonists and Dual GLP-1/GIP Agonist in Croatia, 2017-2024.

Car M, Erceg D, Udovičić M, Bokun T, Rahelić D

Open source

DOI
10.3390/medicina61122210
Published
2025 Dec 15
Container
Medicina (Kaunas, Lithuania)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/medicina61122210,
  title = {National Utilization and Expenditure Trends of GLP-1 Receptor Agonists and Dual GLP-1/GIP Agonist in Croatia, 2017-2024.},
  author = {Car M and Erceg D and Udovičić M and Bokun T and Rahelić D},
  year = {2025},
  journal = {Medicina (Kaunas, Lithuania)},
  doi = {10.3390/medicina61122210},
  url = {https://doi.org/10.3390/medicina61122210}
}

RIS

TY  - JOUR
TI  - National Utilization and Expenditure Trends of GLP-1 Receptor Agonists and Dual GLP-1/GIP Agonist in Croatia, 2017-2024.
AU  - Car M
AU  - Erceg D
AU  - Udovičić M
AU  - Bokun T
AU  - Rahelić D
PY  - 2025
JO  - Medicina (Kaunas, Lithuania)
DO  - 10.3390/medicina61122210
UR  - https://doi.org/10.3390/medicina61122210
ER  - 

APA

M, C., D, E., M, U., T, B., & D, R. (2025). National Utilization and Expenditure Trends of GLP-1 Receptor Agonists and Dual GLP-1/GIP Agonist in Croatia, 2017-2024.. Medicina (Kaunas, Lithuania). https://doi.org/10.3390/medicina61122210

Source records